Central precocious puberty should be taken seriously in children with Leydig cell tumors of the testis after surgical treatment: a tertiary center experience.

Asian journal of andrology Pub Date : 2024-11-01 Epub Date: 2024-08-09 DOI:10.4103/aja202445
Pei Liu, Zong-Han Li, Hong-Cheng Song, Chun-Xiu Gong, Wei-Ping Zhang
{"title":"Central precocious puberty should be taken seriously in children with Leydig cell tumors of the testis after surgical treatment: a tertiary center experience.","authors":"Pei Liu, Zong-Han Li, Hong-Cheng Song, Chun-Xiu Gong, Wei-Ping Zhang","doi":"10.4103/aja202445","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>Central precocious puberty secondary to Leydig cell tumors is rare in children. We retrospectively analyzed the mid- to long-term follow-up data of patients with Leydig cell tumors. The clinical data of 12 consecutive patients who were treated at Beijing Children's Hospital, Capital Medical University (Beijing, China), between January 2016 and October 2023 were retrospectively reviewed. Clinical evaluations, including physical examination, hormone examination, serum tumor marker analysis, abdominal and scrotal ultrasound, chest X-ray, and bone age measurement, were conducted before surgery and at follow-up time points. Surgical approaches were selected according to the individual conditions. Patients with an abnormal hormonal status and suspected of having central precocious puberty were referred to endocrinologists to confirm the diagnosis. Subsequently, gonadotropin-releasing hormone analog therapy was proposed. The mean patient age was 81.3 (range: 40-140) months at the time of the operation. Ten patients had peripheral precocious puberty at admission. All patients had elevated preoperative testosterone levels, whereas tumor marker levels were normal. Testis-sparing surgery was performed in eleven patients, and radical orchiectomy was performed in one patient. The follow-up duration (mean ± standard deviation) was 36.2 ± 25.3 months. Five patients had central precocious puberty, with a mean duration of 3.4 (range: 1-6) months postoperatively. Three patients were receiving gonadotropin-releasing hormone analog therapy, and good suppression of puberty was observed. No risk factors were found for secondary central precocious puberty. There was a high prevalence of central precocious puberty secondary to Leydig cell tumors in our study. Gonadotropin-releasing hormone analog therapy has satisfactory treatment effects. Larger sample sizes and long-term follow-up are needed in future studies.</p>","PeriodicalId":93889,"journal":{"name":"Asian journal of andrology","volume":" ","pages":"617-621"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian journal of andrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/aja202445","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/9 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract: Central precocious puberty secondary to Leydig cell tumors is rare in children. We retrospectively analyzed the mid- to long-term follow-up data of patients with Leydig cell tumors. The clinical data of 12 consecutive patients who were treated at Beijing Children's Hospital, Capital Medical University (Beijing, China), between January 2016 and October 2023 were retrospectively reviewed. Clinical evaluations, including physical examination, hormone examination, serum tumor marker analysis, abdominal and scrotal ultrasound, chest X-ray, and bone age measurement, were conducted before surgery and at follow-up time points. Surgical approaches were selected according to the individual conditions. Patients with an abnormal hormonal status and suspected of having central precocious puberty were referred to endocrinologists to confirm the diagnosis. Subsequently, gonadotropin-releasing hormone analog therapy was proposed. The mean patient age was 81.3 (range: 40-140) months at the time of the operation. Ten patients had peripheral precocious puberty at admission. All patients had elevated preoperative testosterone levels, whereas tumor marker levels were normal. Testis-sparing surgery was performed in eleven patients, and radical orchiectomy was performed in one patient. The follow-up duration (mean ± standard deviation) was 36.2 ± 25.3 months. Five patients had central precocious puberty, with a mean duration of 3.4 (range: 1-6) months postoperatively. Three patients were receiving gonadotropin-releasing hormone analog therapy, and good suppression of puberty was observed. No risk factors were found for secondary central precocious puberty. There was a high prevalence of central precocious puberty secondary to Leydig cell tumors in our study. Gonadotropin-releasing hormone analog therapy has satisfactory treatment effects. Larger sample sizes and long-term follow-up are needed in future studies.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
睾丸莱伊杜氏细胞瘤患儿手术治疗后出现中枢性性早熟应引起重视:一家三级中心的经验。
摘要:继发于Leydig细胞肿瘤的中枢性性早熟在儿童中非常罕见。我们对Leydig细胞肿瘤患者的中长期随访数据进行了回顾性分析。我们回顾性分析了2016年1月至2023年10月期间在首都医科大学附属北京儿童医院(中国北京)接受治疗的12例连续患者的临床资料。在手术前和随访时间点进行了临床评估,包括体格检查、激素检查、血清肿瘤标志物分析、腹部和阴囊超声检查、胸部X光检查和骨龄测量。根据个体情况选择手术方法。激素水平异常并被怀疑患有中枢性性早熟的患者被转诊至内分泌科确诊。随后,医生建议采用促性腺激素释放激素类似物疗法。手术时患者的平均年龄为 81.3 个月(40-140 个月)。10 名患者入院时患有外周性早熟。所有患者术前睾酮水平均升高,而肿瘤标志物水平正常。11名患者接受了保睾手术,1名患者接受了根治性睾丸切除术。随访时间(平均值 ± 标准差)为 36.2 ± 25.3 个月。五名患者出现中枢性性早熟,术后平均持续时间为 3.4 个月(1-6 个月)。三名患者正在接受促性腺激素释放激素类似物治疗,并观察到青春期得到了很好的抑制。没有发现继发性中枢性性早熟的风险因素。在我们的研究中,继发性中枢性性早熟的发病率很高。促性腺激素释放激素类似物疗法的治疗效果令人满意。今后的研究需要更大的样本量和长期的随访。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Androgen receptor inhibitors in treating prostate cancer. Genitourethral foreign bodies: 20-year experience and outcomes from a single center. Associations of Ureaplasma urealyticum infection with male infertility and intrauterine insemination outcomes. PSMA PET/CT in the low- to intermediate-risk prostate cancer: when and why? High-intensity focused ultrasound strategies for treating prostate cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1